We are live on
!
Find out more
SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
144 hedge funds and large institutions have $911M invested in Sage Therapeutics in 2016 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 27 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
156% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 27
45% more call options, than puts
Call options by funds: $66.8M | Put options by funds: $46.1M
4% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 27
1% more funds holding
Funds holding: 143 → 144 (+1)
2% less capital invested
Capital invested by funds: $927M → $911M (-$16M)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
144
Holders Change
+1
Holders Change %
+0.7%
% of All Funds
3.84%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.19%
New
28
Increased
69
Reduced
27
Closed
27
Calls
$66.8M
Puts
$46.1M
Net Calls
+$20.7M
Net Calls Change
+$19.2M
Top Buyers
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$51.8M |
| 2 |
DM
Deerfield Management
New York
|
-$35.7M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$33.8M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$12.3M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.17M |
